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Abstract 
The primary structure of bovine a,-antiplasmin (a,AP) has been determined from cDNA and partial peptide sequencing. Mature bovine a,AP 
contains 470 residues and is 6 residues longer than human cc@. Alignment of the two protein sequences show that 8 1% of their amino acid residues 
are identically located. Bovine a,AP has 5 N-linked carbohydrate groups, of which four are found in human a,AP (AsnlO5,274,288 and 295). Asn227 
is the fifth carbohydrate attachement site in bovine a,AP. The 3 Cys residues of bovine a,AP are present as an unpaired residue (Cysl31) and as 
a pair in a disulfide bridge (Cys49Cysl22). The assignment of the bridge in bovine a,AP is at variance with the previous assignment of the two 
disulfide bridges in human a,AP [L&en, H.R. et al. (1987) Eur. J. Biochem. 166, 565-5741. 
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1. Introduction 
a,-Antiplasmin (a&‘) is the primary inhibitor of the 
plasma protease plasmin [l-3]. It is a member of the 
serpin family of proteins which has been identified in 
viruses, plants, insects and higher animals [4,5]. Most 
mammalian plasma serpins participate in the control of 
thrombolysis, fibrinolysis, complement activation and 
inflammation. They interact with their target protease 
through a particularly exposed reactive site loop (RSL) 
[41* 
a,AP diverged early from the line leading to the in- 
flammatory serpins a,PI and a,ACT [5-71. In several 
species the latter proteins form multigene families [8-lo] 
in which the RSL sequences how great diversity, and in 
which the distinction between orthologous and paralo- 
gous proteins cannot always be made. 
However, as discussed recently [lo], orthologoues of 
a,PI are indeed strongly related throughout their entire 
sequences, and it can be expected that the sequences of 
other orthologous serpins, including their RSLs, will be 
very similar. This is also apparent from a comparison of 
the sequences of human and bovine AT111 and PAI- 
[ 1 l-141. While the sequence of human a,AP has been 
determined [ 15,161 only partial sequence data for bovine 
aTAP have been available [17]. 
Here we report the amino acid sequence of bovine 
a,AP deduced from cDNA and peptide sequencing. Bo- 
vine a,AP contains 5 sites of N-linked glycosylation, 1 
disulfide bridge and an unpaired Cys residue which all 
have been located. The data add further strength to the 
view that orthologous serpins are strongly related 
throughout their sequences. 
2. Materials and methods 
*Corresponding author. Fax: (45) 8942 2679. 
Abbreviations: a,Ap, human and bovine a,-antiplasmin; ATIII, 
antithrombin III; PAI-I, plasminogen activator inhibitor I; a,PI, 
a,-antitrypsin; a,ACT, a,-antichymotrypsin; TGA, thioglycollic acid; 
TFA, tritluoroacetic acid; PVDF, polyvinylidene difluoride; PAGE, 
polyacrylamide gel electrophoresis. Solutions: 20 x SSPE: 3.0 M NaCl, 
0.3 M sodium phosphate, 0.02 M EDTA, pH 7.4; 1 x SSC: 150 mM 
NaCl, 15 mM trisodium citrate; 100 x Denhard: 2% bovine serum albu- 
min, 2% polyvinylpyrrolidone and 2% Ficoll-400. 
The nucleotide sequence presented here has been submitted to the 
EMBLKienbank database under accession o. X78436. 
2.1. Enzymes and reagents 
Restriction endonuclases, T4 DNA ligase, nick translation kit and 
trypsin were from Boehringer Mannheim. As revealed by the digestion 
pattern of bovine a,AP (see below) trypsin was contaminated with 
chymotrypsin. Plasmid pPAAP, with an insert encoding human a,AP 
1181 was a kind gift from R. Liinen and L. Nelles. Universitv of Leuven. 
Belgium. [a-‘*P]dATP and [“S]dATP were from Amersham. The bo: 
vine liver Lgt-11 phage library was from Clontech. DNA sequence 
reactions were carried out using Sequenase V2.0 (United States Bio- 
chemical). Antibodies were from Dako, and Protein-A Sepharose was 
from Pharmacia. 
2.2. Screening, cloning and sequencing of bovine RAP cDNA 
About 400,000 plaques from an adult male bovine liver &t-l 1 phage 
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library were screened with a mixture of the two nick translated EcoRI 
fragments of plasmid pPAAP [IS]. Together, these probes contained the 
entire coding sequence for human cc,AP. Hybridisations to nitrocellu- 
lose tilters were done in 5 x SSPE, 2 x Denhardt, 0.5% SDS and 100 
,@nl salmon sperm DNA overnight at 68°C. The filters were washed 
two times (15 min each) with 2 x SSC, 0.1% SDS at 68’C and autora- 
diographed. DNA from purified plaques was digested with restriction 
endonuclease EcoRK and separated in 1% agarose and transferred to 
nitr~ll~o~ by Southern blotting 1191. The DNA fragments which 
hybridized to the insert of pPAAP were subcloned in plasmid pUC19. 
The DNA sequence was determined by using primers close to the EcoRI 
cloning site in pUC19 and primers complementary to the successively 
determined stretches of sequence on both strands. 
2.3. Northern blot analysis 
RNA was isolated from homogenized tissue by CsCl gradient centrif- 
ugation and size-fractionated by fo~~dehyde/agarose gel electro- 
foresis [20,21]. After transfer to nitrocellulose the tilter was hybridised 
with the nick translated EcoRI fragment of clone API 1 (see below). 
2.4. Localization of N-linked carbohydrate and disulfide bridge 
Bovine u,AP was purified as described [17]. Three hundred ,ug pro- 
tein was dissolved in 400 ~170% HCGGH and incubated for 20 h in 
the dark with 5 mg of CNBr. After lyophi~sation the material was 
dissolved in 600 ~10.1 M NI-I,HCO, and incubated with 5 yg trypsin 
for 5 h at 37°C. The peptides were separated on a C-18 Nucleosil 
column (4 x 250 mm) using a gradient of acetonitrile in 0.1% TFA as 
in [17]. The amino acid composition of all fractions were determined 
and peptides containing half-cystine or glucosamine selected for se- 
quence analysis. 
2.5. Amino acid and sequence analysis 
Prior to hydrolysis (6 M HCl/O. 1% phenol for 16 h at 1lO’C) samples 
were oxidised with 1 M performic acid for 20 min at room temperature. 
From these hydrolysates HPLC fractions containing half-cystine and 
glucosamine were identified. To determine cysteine in non-oxidised 
samples hydrolysis was carried out in the presence of 5% TGA. Amino 
acids were determined by cation-exchange c~omato~aphy 122,231. 
Sequence analysis was done by Edman degradation on an AI? 477 
A instrument with on-line PTH-amino acid analysis. The Normal-l 
reaction and conversion cycles were used. 
3. RemIts and discussion 
3.1. Cloning, Northern blot analysis and sequencing of 
bovine %AP 
From a ;2gt-11 bovine liver library two overlapping 
clones (APll and AP20) (Fig. 1A) were isolated which 
together contained the coding sequence for bovine a,AP, 
most of the 3‘-untranslated region including the polyad- 
enylation signal, and 108 bases located 5’ of the N-termi- 
nal Phe residue of mature bovine a,AP [ 171. The cDNA 
sequence ncodes a 492 amino acid precursor of bovine 
a&P (Fig. 1B). 
The EcoRI fragment of clone APl 1 was used as probe 
in Northern blot analysis of mRNA from different bo- 
vine tissues (mammary gland, skeletal muscle, heart, 
liver). As seen previously [16], hybridisation was found 
mainly to liver RNA. One band was seen with the size 
of approx. 2.2 kb. No hybridisation was found to heart 
RNA, but weak signals were seen in muscle and mam- 
mary gland RNA (not shown). 
A hydrophobic signal peptide of 22 residues was found 
to precede mature a,AP. A Gln and Ser in position -1 
and -3, respectively, is in accordance with the -1 to -3 
rule for signal peptidases, though Gln at -1 is rare [24]. 
The sequence of bovine a,AP predicted from its 
cDNA differs at three positions from that determined 
from N-terminal sequence analysis [17]: At position 6 
(Thr vs. Gin), 18 (Gln vs. Pro) and 21 (Gln vs. Glu). A 
re-exa~nation of the N-terminal sequence of u,AP re- 
vealed two PTH-amino acids in step 6 (Thr and Gln) and 
18 (Gln and Pro). This is likely to be due to heterogeneity 
or breed differences as the protein was purified from 
pooled plasma. The residue at position 21 was previously 
determined as Glu, possibly the result of deamidation of 
Gln during sequencing. The sequences of 229 residues 
were obtained from 17 peptide fragments (Fig. 2) two of 
which were reported before [17]. No additional differ- 
ences were found for the stretches determined from pep- 
tide sequencing. 
3.2. ~orn~ar~on of the sequenced of bovine azAP and 
human a,AP 
The sequences of bovine and human a,AP have 81% 
residues in common (Fig. 2). This is lower than the score 
obtained by comparing the sequences of human and bo- 
vine AT111 (89%) [11,12] and PAI- (86%) 113,141, but 
higher than the value found when comparing human and 
bovine a,PI (72%) [25,26]. This range of scores is typi- 
cally seen when the sequences of orthologous human and 
bovine plasma proteins are compared. 
As the sequence similarity extends through the signal 
peptide to the initiator Met residue, pro~ssing would be 
expected to occur at the same site. However, mature 
bovine a,AP is 6 residues longer than human c&P [17]. 
This can be explained by the deletion in human a&P of 
Gln(-1) found in bovine gAP, hence changing the proc- 
essing site 6 residues towards the C-terminus. Gln20 of 
bovine a&P is presumably the contempt of Gln14 of 
human a,AP (revised numbering [IT), which is impor- 
tant for transglutaminase-mediated cross-linking of 
azAP to fibrin [27]. 
Residues P15-P’15 of the RSL are particularly well 
conserved in bovine and human azAP (87% identity) 
indicating the r~uirement of a strictly specified structure 
for interaction with the active site of plasmin. In con- 
trast, the C-terminal extensions of bovine and human 
gAP (starting at residue 414 in bovine azAP) have only 
69% residues in common. This is surprising since this 
region is known also to be impo~ant for the interaction 
of a&P and plasmin [ZS]. However, Lys448 and the 
C-terminal Lys464 of human a&P previously shown to 
interact of with plasmin [28,29] are conserved in bovine 
a,AP as well as 4 other Lys residues of unknown func- 
tional role (Fig. 2). Tyr463 of human azAP is sulfated 
[30], and this residue as well as the preceding 3 acidic 
residues commonly associated with sulfation [31] are 
conserved in bovine a,AP, suggesting that it is modified 
in the same way. 
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3.3. Localization of carbohydrate dttuachment sites in 
bavine %AP 
Bovine o@P contains 3.1% (w/w) 8lucosamine [X7] 
and its cDNA sequence predicts 5 potential N-glycosyla- 
tion sites (Figs. I B and 2). Peptides ~o~~~~~g ghzcosam- 
ine were identified, from a CNBr!tryptic digest (Fig. 3). 
Upon sequence analysis of these, a gap at the potential 
glycosylation site was taken as evidence for the attach- 
ment of carbohydrate The results showed that the 5 
potential sites, AsnlO5, Asn227, Asn274, Asn288 and 
Asn295, were all ~~~sy~a~ in bovine dzM Apart 
from Asn227, these sites are the same as in human u,AP 
[15], emphasizing the strong similarity of the 2 ortholo- 
gous proteins. 
3.4. ~~~~d~ EronB ~~~~~~~~t ~~~~~~~ qAP 
Bovine a,Ap contains 3 Cys residues (Fig. IA) and 
these residues (positions 49, 122 and 131) correspond to 
the Cys residues 43, 116 and 125 of human a,AP The 
counterpart of Cys76 in human azAP is Arg82 in bovine 
ftzAP (Fig. 2’) 
Halfkys containing pePtides genemted by CNffr and 
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Fig. 2. Alignment of the protein sequences of bovine(b) and human (h) a,Af? Two dots (r) indicate identical and one dot c) chemically similar residues. 
The reactive site P,-F, residues are shown with(v). The 5 glycosylation sites are shown with (+). The paired Cys residues in bovine a,AP are connected 
by a line, and the unpaired Cys residue is marked with an (*). The 4 Cys residues of human arAP are shown with (A). 
tryptic digestion of bovine a,AP were detected in frac- 
tions 51-67 (Fig. 3). Peptide 53 gave a single sequence 
Leu-Xaa-Gln-Asp-Leu-Gly-Pro-Gly-Ala-Phe-Arg corre- 
sponding to residues Leul30-Arg140 of bovine a&P 
(Fig. 2). Since the composition of performic acid oxidised 
peptide 53 (Cya, 0.9; Asx, 1.0; Glx, 1.1; Pro, 1.0; Gly, 2.0; 
Ala, 1.1; Leu, 1.8; Phe, 1.1; Arg, 0.9) agreed with that 
expected from residues 130-140, the results indicated 
that Cys131 is unpaired. Curiously, by conducting hy- 
drolysis of peptide 53 (which had not been treated with 
per-formic acid) in the presence of 5% TGA Cysl31 was 
also recovered as cysteic acid, possibly the result of oxi- 
dation of cysteine by CNBr as previously described [32]. 
As expected, peptide 53 did not incorporate radioactivity 
when treated with 14C-labelled ICHJONH, at pH 8.0 
for 2 h (not shown). Since native bovine a,AP likewise 
did not incorporate ra~oactivity in the same conditions, 
Cysl31 is probably present as a buried unpaired Cys 
residue in native bovine a,AP 
The composition of performic acid oxidised peptide 63 
(Cya, 1.8; Asx, 2.0; Ser, 1.9; Glx, 2.2; Pro, 2.9; Gly, 1.2; 
Ala, 1.9; Val, 0.9; Leu, 3.9; His, 2.0; Lys, 2.0; Arg, 1.1) 
was in agreement with that peptide being a disulfide 
bridged set consisting of the mates LysM-Lys50 and 
Glu113-Arg129. Upon sequence analysis of peptide 63 
two sequences, Lys-~a-Pro-Glu-As~Xaa-Lys and Glu- 
Val -Leu- His -Ala -Asp-Ser-Gly-Pro-Xaa-Leu-Pro-His- 
Leu-Leu-Ser-Arg, corresponding to Lys44-Lys50 and 
Glull3-Arg 129 respectively, were found in equimolar 
yield. However, no bis-PTH-Cys, was observed in cycle 
10, due to its instability during extended Edman degra- 
dations. 
Rechromatography of peptide 63 (retention time 28.2 
min) after reduction and carboxamidation, resulted in 
separation of the alkylated peptides Lys44-Lys50 (reten- 
tion time 9.9 min) and Glu113-Arg129 (retention time 
30.5 mm), as dete~n~ by amino acid analysis. From 
the combined results it is concluded that a disnlfide 
bridge connects Cys49 and Cys122 in bovine a,AP. 
Due to the presence of a slight chymotryptic activity 
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Fig. 3. Reversed-phase HPLC separation of bovine a,AP tryptic peptides on Nucleosil IO@5 C18. The peptides were eluted (50°C) at a flow rate 
of 1 ml/mm with a linear gradient (060% B in 60 mm) formed from 0.1% TFA (solvent A) and 90% acetonittile containing 0.075% TFA (solvent 
B). Vertical bars indicate the relative amount of cysteic acid. The fractions found to contain glucosamine are marked with (a). Selected peptides 
were rechromatographed using shallow gradients of solvent B. The position of peptides 53 with an unpaired cys-residue and peptide 63 with a disuhide 
bridge are shown. 
in the trypsin preparation used, variants of the peptide 
set represented by peptide 63 were also found in fractions 
55-61. 
It was suggested previously from compositional analy- 
sis that in human a,AP a disulfide bridge connects Cys76 
and Cysl16 1151. Further, it was suggested that Cys43 
and Cys125 are disulfide bridged (revised numbering of 
human gAP [17], Figs. 1A and 2). The latter assignment 
was made by compositional analysis of peptides ob- 
tained after reduction and alkylation of insoluble mate- 
rial [15]. 
The assignment of the bridges Cys76-Cysll6 and 
Cys43-Cys125 in human &AP is at variance with the 
assignment of the bridge Cys49-Cys122 in bovine r@? 
However, by comparison with the three-dimensional 
structure of human a,PI [33] it is found that Cys76 of 
human RAP is located in the loop between helix A and 
B, and that Cys116 is located in helix D. In effect, these 
residues are separated by the length of helix A (approx. 
40 A) which precludes connection by a distide bond. 
In contrast, the presence of a disulfide bond between 
Cys49 and Cys122 in bovine a+P is compatible with the 
thr~-dimensional st~c~re of a,PI, where the residue 
corresponding to Cys49 is located at the N-terminal part 
of helix A and in proximity to the residue corresponding 
to Cys122 in helix D. In analogy with bovine a,AP 
Cys43 and Cysl16 of human a&P could be bridged. 
Whether Cys76 and Cys 125 of human a,AP are unpaired 
as Cys 13 1 of bovine a,AP is not known. 
3.5. Functional aspects of bovine qAP 
In human and bovine a,AP the f~c~onally impor- 
tant RSL sequence, the factor XIIIa cross-linking site 
and the C-terminal lysine residue are conserved as ex- 
pected for the cognate inhibitor of plasmin. Indeed, a 
recent study (SC., U. Christensen and L.S.-J., submit- 
ted) has shown that the association rate for inhibition of 
bovine plasmin by bovine azAP is fast f/c,_, = 1.7 x lo6 
M-’ . s-‘). The importance of the lysine binding 
sites in this reaction was also investigated, and a hitherto 
overlooked role of kringles 4 and/or 5 in bovine plasmin 
was revealed. In addition to plasma, bovine azAP has 
recently been found in milk (SC., T. Wiegers, J. Her- 
mansen and L.S.-J., submitted), where it might have a 
similar function, since it is found to be complexed with 
midiplasmin (kringles 4 and 5 bridged to plasmin light 
chain). 
~c~o~~dg~nts: We thank Drs. Roger Lijnen and Luc Nelles for 
donating the human a&P cDNA clone and Tove Wieaers and Lene 
R.&en& for te&ni&l assistance. This work was supported by the 
Danish Ministry of Agriculture, the Danish Dairy Board, and the 
Danish Biomembrane Center. 
S. Christensen et al. IFEBS Letters 343 (1994) 223-228 228 
References 
[l] Collen, D. (1976) Eur. J. Biochem. 69, 209-216. 
[2] Moroi, M. and Aoki, N. (1976) J. Biol. Chem. 251, 59565965. 
[3] Mtillertz, S. and Clemmensen, I. (1976) Biochem. J. 159, 545-553. 
[4] Huber, R. and Carrell, R.W. (1989) Biochemistry 28, 8951-8966. 
[5] Kanost, M.R., Sarvamangala, VP. and Wells, M.A. (1989) J. Biol. 
Chem. 264, 965-972. 
[6] Bao, J.-J., Sifers, R.N., Kidd, V.J., Ledley, ED. and Woo, S.L.C. 
(1987) Biochemistry 26, 7755-7759. 
[7] Carrell, R.W. and Boswell, D.R. (1986) in: Proteinase Inhibitors 
(Barrett, A.J. and Salvesen, G.S., Eds.) pp. 403-420, Elsevier, 
Amsterdam. 
[8] Hill, R.E. and Hastie, N.D. (1987) Nature 326, 9699. 
[9] Inglis, J.D. and Hill, R.E. (1991) EMBO J. 10, 255-261. 
[lo] Patterson, S.D. (1991) Comp. Biochem, Physiol. lOOB, 439454. 
[ll] Bock, SC., Wion, K.L., Vehar, G.A. and Lawn, R.M. (1982) 
Nucleic Acids Res. 10, 8113-8125. 
[12] Mejdoub, H., Le Ret, M., Boulanger, Y., Maman, M., Choay, J. 
and Reinholt, J. (1991) J. Prot. Chem. 10, 205212. 
[13] Mimuro, J., Sawdey, M., Haitiori, M. and Loskutoff, D.J. (1989) 
Nucleic Acids Res. 17, 8872. 
[14] Loskutoff, D.J., Linders, M:, Kiejer, J. Veerman, H., Heerik- 
huizen, H. and Pannekoek, H. (1987) Biochemistry 26,3763-3768. 
[15] Lijnen, H.R., Holmes, W.E., Van Hoef, B., Wiman, B., Rodriguez, 
H. and Collen, D. (1987) Eur. J. Biochem. 166, 565-574. 
[16] Holmes, W.E., Nelles, L., Lijnen, H.R. and Collen, D. (1987) J. 
Biol. Chem. 262, 1659-1664. 
[17] Christensen, S. and Sottrup-Jensen, L. (1992) FEBS Lett. 312, 
100-104. 
[18] Holmes, W.E., Lijnen, H.R. and Collen, D. (1987) Biochemistry 
26, 5133-5140. 
[19] Southern, E.M. (1975) J. Mol. Biol. 98, 503-517. 
[20] Chirgwin, J.M., Przybyla, A.E., McDonald, R. J. and Rutter, W.J. 
(1979) Biochemistry 18, 5294-5299. 
[21] Sambrook, J, Fritsch, E.F., and Maniatis, T. (1988) Molecular 
Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor 
Lab., Cold Spring Harbor, NY. 
[22] Barkholt, V. and Jensen, A.L. (1989) Anal. Biochem. 177, 318 
322. 
[23] Sottrup-Jensen, L. (1993) Biochem. Mol. Biol. Int. 30, 789-794. 
[24] Von Heijne, G. (1984) J. Mol. Biol. 173, 243-251. 
[25] Kurachi, K., Chandra, T., Friezner, S.J., White, T.T., Marchioni, 
T.L., Woo, S.C. and Davie, E.W. (1981) Proc. Natl. Acad. Sci. 
USA 78, 68266830. 
[26] Sinha, D., Bakhshi, M.R. and Kirby, E.P. (1992) Biochim. Bio- 
phys. Acta 1130,20 -212. 
[271 Kimura, S. and Aoki, N. (1986) J. Biol. Chem. 261,15591-15596. 
[28] Sasaki, T., Morita, T. and Iwanaga, S. (1986) J. B&hem. (Tokyo) 
99, 1699-1705. 
[29] Hortin, G.L., Beverly, L.T. and Fok, K.F. (1989) Throm. Res. 54, 
621-632. 
[30] Hortin, G.L., Fok, K.F., Toren, P.C. and Strauss, A.W. (1987) J. 
Biol. Chem. 262, 3082-3085. 
[31] Rosenqvist, G.L. and Nicholas, Jr., H.B. (1993) Protein Sci. 2, 
215-222. 
[32] Smith, S. and Kyte J. (1989) Biochemistry 29, 3469-3482. 
[33] Lobermann, H., Tokuoka, R., Deisenhofer, J. and Huber, R. 
(1984) J. Mol. Biol. 177, 531-556. 
